Medicare Enrolled

Dr. Richard Lewis, MD

Urology Physician · Jacksonville, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
710 LOMAX ST, Jacksonville, FL 32204
9043556583
Registered in NPPES since 2007
NPI: 1245371095 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lewis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lewis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lewis

Dr. Richard Lewis is an urology physician in Jacksonville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lewis performed 22,077 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Lewis received a total of $4,485 from 48 pharmaceutical and/or device companies across 197 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lewis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 5% volume in FL $4,485 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
22,077
Medicare services
Top 5% in FL for urology physician
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 18,240 $19 $75
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,131 $90 $406
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
882 $2 $15
Leuprolide acetate (for depot suspension), 7.5 mg 615 $135 $587
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
206 $26 $100
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
175 $11 $44
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
136 $8 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
132 $67 $287
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
116 $79 $350
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
61 $44 $200
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
57 $8 $60
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
56 $181 $739
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
48 $61 $225
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
46 $113 $530
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
35 $40 $120
Injection, garamycin, gentamicin, up to 80 mg 32 $2 $10
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
22 $104 $430
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
21 $6 $32
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $75 $355
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
17 $188 $795
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
17 $45 $182
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
14 $141 $611
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,485
Total received (2018-2024)
Avg $641/year across 7 years
Top 44% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
197
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$796
2023
$947
2022
$317
2021
$314
2020
$114
2019
$1,119
2018
$879

Payments by company (2024)

Calyxo, Inc.
$141
Bayer Healthcare Pharmaceuticals Inc.
$140
PFIZER INC.
$134
Sumitomo Pharma America, Inc.
$61
Astellas Pharma US Inc
$59
PROGENICS PHARMACEUTICALS, INC.
$58
Merck Sharp & Dohme LLC
$55
UROGEN PHARMA, INC.
$54
Blue Earth Diagnostics Limited
$43
Boston Scientific Corporation
$18
IMMUNITYBIO, INC.
$18
Agiliti Surgical, Inc.
$15
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,006
PFIZER INC.
$373
Janssen Biotech, Inc.
$333
Dendreon Pharmaceuticals LLC
$315
Foundation Medicine, Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$158
Boston Scientific Corporation
$152
Amgen Inc.
$149
Calyxo, Inc.
$141
Merck Sharp & Dohme Corporation
$137
Axonics, Inc.
$115
Blue Earth Diagnostics Limited
$105
Merck Sharp & Dohme LLC
$92
Avadel Specialty Pharmaceuticals, LLC
$86
Endo Pharmaceuticals Inc.
$85
Tolmar, Inc.
$81
Rochester Medical Corporation
$77
Bayer HealthCare Pharmaceuticals Inc.
$70
AbbVie, Inc.
$65
BOSTON SCIENTIFIC CORPORATION
$64
Sun Pharmaceutical Industries Inc.
$62
Sumitomo Pharma America, Inc.
$61
MEDIVATION FIELD SOLUTIONS LLC
$60
PROGENICS PHARMACEUTICALS, INC.
$58
UROGEN PHARMA, INC.
$54
Novartis Pharmaceuticals Corporation
$41
Myovant Sciences Inc.
$35
Progenics Pharmaceuticals, Inc.
$29
Retrophin, Inc.
$23
BIOTISSUE HOLDINGS, INC.
$23
Myriad Genetic Laboratories, Inc.
$21
Laborie Medical Technologies Corp.
$19
Cook Medical LLC
$18
IMMUNITYBIO, INC.
$18
Smith & Nephew, Inc.
$17
PROCEPT BioRobotics Corporation
$17
AbbVie Inc.
$16
Ferring Pharmaceuticals Inc.
$16
Aytu BioScience, Inc
$15
UroGen Pharma, Inc.
$15
Agiliti Surgical, Inc.
$15
Clarus Therapeutics Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$12
C. R. BARD, INC. & SUBSIDIARIES
$12
Shire North American Group Inc
$12
Antares Pharma, Inc.
$12
Allergan Inc.
$12
Olympus America Inc.
$12
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · Axumin · BOTOX THERAPEUTIC · CVAC ASPIRATION SYSTEM · Cook Medical Holmium Laser Fiber · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lasers · Lumenis Pulse 120H · Lupron · MYRBETRIQ · NATPARA (PARATHYROID HORMONE) · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolaris · Prolia · RYBREVANT · SUTENT · Santyl · TOVIAZ · VESICARE · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an urology physician in Jacksonville?
Compare urology physicians in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians in nearby ZIP areas
75
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
ASCENSION ST VINCENT'S RIVERSIDE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lewis is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lewis experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lewis performed 18,240 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lewis receive payments from pharmaceutical companies?
Yes. Dr. Lewis received a total of $4,485 from 48 companies across 197 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lewis's costs compare to other urology physicians in Jacksonville?
Dr. Lewis's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lewis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →